Cardinal Health Inc. logo

Cardinal Health Inc. (CAH)

Market Open
5 Dec, 14:38
NYSE NYSE
$
199. 36
+0.17
+0.09%
$
50.64B Market Cap
164.74 P/E Ratio
2.02% Div Yield
45,859 Volume
5.74 Eps
$ 199.19
Previous Close
Day Range
199.31 200.25
Year Range
114.6 214.93
Want to track CAH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 54 days
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seekingalpha | 1 day ago
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seekingalpha | 2 days ago
4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026

4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026

High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.

Zacks | 4 days ago
Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know

Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 week ago
Here's Why Cardinal Health (CAH) is a Strong Value Stock

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 week ago
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 week ago
Cardinal (CAH) Upgraded to Buy: Here's Why

Cardinal (CAH) Upgraded to Buy: Here's Why

Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 week ago
Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 week ago
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 week ago
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

Here's Why Cardinal Health (CAH) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 week ago
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript

Cardinal Health, Inc. ( CAH ) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Matt Sims - Vice President of Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good morning, everybody. Thanks for joining us.

Seekingalpha | 3 weeks ago
Loading...
Load More